28.08.2012
- AstraZeneca has poached Pascal Soriot from rival Roche Holding to be its new chief executive, hoping his track record in drug innovation and dealmaking can revive a company...
16.08.2012
- A federal appeals court on Thursday revived its decision to uphold Myriad Genetics's patents on two genes linked to breast and ovarian cancer, after the U.S. Supreme Court told it...
13.08.2012
- Ireland's Elan is to spin off its Neotope drug discovery business platform as a separate public company, making Elan immediately profitable and potentially more appealing as a...
13.08.2012
- Molecular Profiles, a specialist contract research and manufacturing organisation, announced that it has entered into a strategic alliance with Onyx Scientific, a contract...
03.08.2012
- Global biotech merger volume has reached levels not seen in four years as big pharmaceutical companies pursue deals to get access to new drugs, with bankers saying therapeutic...
01.08.2012
- Life Technologies on Tuesday lowered the high end of its full year profit forecast and said revenue would come in at the low end of its prior outlook, citing unfavorable foreign...
25.07.2012
- GlaxoSmithKline warned on Wednesday that sales in 2012 would be flat as pressure on drug prices intensifies in Europe, due to government austerity measures aimed at curbing...
21.07.2012
- Aggressive consolidation among U.S. and European generic drugmakers is putting pressure on smaller competitors in the industry, whose best hope of surviving a brewing price war may...
21.07.2012
- Myriad Genetics illegally patented acts of nature when it claimed ownership of two genes linked to cancer, the federal government told an appeals court on Friday. Lawyers from...
19.07.2012
- Actelion raised its earnings outlook for 2012 on Thursday as cost cuts helped Europe's biggest biotech company to post a first-half profit despite its most important drug facing...
